Loading…
IMCG and EYES share 3.8% of their holdings.
| Side by side | IMCG | EYES |
|---|---|---|
| Strategy | US Stock Styles · Mid cap | Unsorted |
| Expense ratio | 0.06% | 0.35% |
| Cost per year on $10k | $6 | $35 |
| Trailing 12-mo yield | 0.67% | 0.00% |
| Income per year on $10k | $67 | $0 |
| YTD | +17.3% | — |
| 1 year | +15.2% | — |
| 3 years · per year | +21.0% | — |
| 5 years · per year | +5.6% | — |
| Worst drop · 1Y | −10.2% | — |
| Volatility · 1Y | 17.5% | — |
| Holdings | 259 | 30 |
| Assets | $4.0B | $1M |
| Leverage | None | None |
| Since | 2004 | 2026 |
Highlighted = best in the row. Returns include dividends.